Pharma channel feed

Te­va charged — again — for al­leged role in fix­ing gener­ic drug prices, this time by the De­part­ment of Jus­tice

5 years ago

That new biotech com­pound Arie Bellde­grun & Co. have been build­ing in Sea­port? It turns out one fast-grow­ing de­vel­op­er took the whole thing

5 years ago

Sev­en PD-(L)1 play­ers could be vy­ing for a place on Chi­na's drug re­im­burse­ment list. How far will they go?

5 years ago
China

Bris­tol My­ers joins the lab rush in Cam­bridge with plans to con­sol­i­date R&D ops in a biotech cam­pus now un­der con­struc­tion

5 years ago

Opi­oids, price-fix­ing and now kick­backs. Pros­e­cu­tors add an­oth­er ‘en­rich­ing’ scheme to the claims against Te­va

5 years ago

Fed­er­al judge de­nies Mar­tin Shkre­li all but one mo­tion to dis­miss mo­nop­oly claims in the FTC's Dara­prim law­suit

5 years ago
People

Mer­ck pre­pares to fi­nal­ly break ground on $1.3B Lon­don re­search hub

5 years ago
R&D

Mar­tin Shkre­li con­tin­ued to or­ches­trate an­ti-com­pet­i­tive schemes for Dara­prim be­hind bars — FTC

5 years ago
People

The FDA just ap­proved the third Duchenne MD drug. And reg­u­la­tors still don’t know if any of them work

5 years ago
FDA+

Bris­tol My­ers Squibb com­mits $300 mil­lion to com­bat racial dis­par­i­ties, but de­clines to re­lease own de­mo­graph­ic da­ta

5 years ago

Mar­tin Shkre­li's in­fa­mous Dara­prim falls off top 20 most ex­pen­sive drugs list

5 years ago

Ei­sai is cre­at­ing a new US cor­po­rate, R&D HQ in Roche’s old Nut­ley, NJ cam­pus

5 years ago

Covid-19 roundup: Cure­Vac beefs up its uni­corn IPO dreams as bil­lion­aire own­er takes this Covid-19 mR­NA play­er on a forced march to Nas­daq; Ko­dak's $765M deal is put on hold

5 years ago
Outsourcing
Coronavirus

FDA takes the lead on defin­ing es­sen­tial un­der Trump's 'Buy Amer­i­can' ex­ec­u­tive or­der — as phar­ma warns of sup­ply chain dis­rup­tion

5 years ago
Outsourcing
FDA+

Trump reach­es for his pen as long-await­ed ex­ec­u­tive or­der on drug man­u­fac­tur­ing on-shoring fi­nal­ly ar­rives — re­ports

5 years ago
Outsourcing

Sev­en plucky di­ag­nos­tics com­pa­nies win a $249M round of con­tracts af­ter sur­viv­ing NI­H's Covid-19 'Shark Tank' com­pe­ti­tion

5 years ago
Coronavirus

Bio­gen's last-ditch pitch for an in­junc­tion to pro­tect Tec­fidera is de­nied, paving way for My­lan gener­ic

5 years ago

Genen­tech slash­es near­ly 500 jobs in strate­gic shift to 'lo­cal health­care ecosys­tems.' Clin­i­cal spe­cial­ists make up the biggest group

5 years ago
R&D

Mod­er­na, Pfiz­er be­gin to give glimpse of Covid-19 vac­cine pric­ing — and prof­its

5 years ago
Coronavirus

Af­ter down year, 2020 brings new cash in­to Mass­a­chu­setts biotech

5 years ago
Financing

Trump looks to ham­mer down drug prices with 4 ex­ec­u­tive or­ders

5 years ago

So­bi's high-pri­or­i­ty rare dis­ease drug runs in­to a wall at EMA

5 years ago
FDA+

Could a patent rul­ing threat­en Mod­er­na’s Covid-19 vac­cine?

5 years ago

As­traZeneca COPD drug fi­nal­ly gets OK from FDA, inch­ing clos­er to GSK leader

5 years ago
FDA+
First page Previous page 255256257258259260261 Next page Last page
A service from the Financial Times